CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study (Q81205526)
scientific article published on 01 November 2004
Language:
(P31) (Q13442814)
(P50) (Q67208955)
(P304) 693-701
(P433) 6
(P478) 24
(P577) Monday, November 1, 2004
(P921) (Q134808)
(Q967453)
(P1433) (Q6294961)
(P1476) "CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study" (language: en)
(P2093) C L Cooper
H L Davis
M L Morris
S M Efler
M Al Adhami
A M Krieg
J Heathcote
(P2860) (Q44523432)
(Q73929492)
(Q73502903)
(Q74463505)
(Q34183174)
(Q45085148)
(Q64882072)
(Q73389200)
(Q33887022)
(Q33947147)
(Q51030792)
(Q74486539)
(Q44505548)
(Q34542287)
(Q73832885)
(Q37365416)
(Q38656202)
(Q33894481)
(Q73175525)
(Q45978807)
(Q36380885)
(Q43682312)
(Q78816478)
(Q73814892)
(Q38872315)
other details
description scientific article published on 01 November 2004

External Links